Hexadecanamide alleviates Staphylococcus aureus-induced mastitis in mice by inhibiting inflammatory responses and restoring blood-milk barrier integrity
PLOS Pathogens · 10.11.2023 · 19 (11) · e1011764
DOI: 10.1371/journal.ppat.1011764 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 10.11.2023. Verfasst von Lijuan Bao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, China. Hauptthemen laut MEDLINE: Staphylococcus aureus, Mastitis. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Subacute ruminal acidosis (SARA) has been demonstrated to promote the development of mastitis, one of the most serious diseases in dairy farming worldwide, but the underlying mechanism is unclear. Using untargeted metabolomics, we found hexadecanamide (HEX) was significantly reduced in rumen fluid and milk from cows with SARA-associated mastitis. Herein, we aimed to assess the protective role of HEX in Staphylococcus aureus ( S . aureus )- and SARA-induced mastitis and the underlying mechanism. We showed that HEX ameliorated S . aureus -induced mastitis in mice, which was related to the suppression of mammary inflammatory responses and repair of the blood-milk barrier. In vitro , HEX depressed S . aureus -induced activation of the NF-κB pathway and improved barrier integrity in mouse mammary epithelial cells (MMECs). In detail, HEX activated PPARα, which upregulated SIRT1 and subsequently inhibited NF-κB activation and inflammatory responses. In addition, ruminal microbiota transplantation from SARA cows (S-RMT) caused mastitis and aggravated S . aureus -induced mastitis, while these changes were reversed by HEX. Our findings indicate that HEX effectively attenuates S . aureus - and SARA-induced mastitis by limiting inflammation and repairing barrier integrity, ultimately highlighting the important role of host or microbiota metabolism in the pathogenesis of mastitis and providing a potential strategy for mastitis prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, China.
ORCID-Profile: Yunhe Fu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Bao, L., Sun, H., Zhao, Y., Feng, L., Wu, K., Shang, S., Xu, J., Shan, R., Duan, S., Qiu, M., Zhang, N., Hu, X., Zhao, C., & Fu, Y. (2023). Hexadecanamide alleviates Staphylococcus aureus-induced mastitis in mice by inhibiting inflammatory responses and restoring blood-milk barrier integrity. PLOS Pathogens, 19(11), e1011764. https://doi.org/10.1371/journal.ppat.1011764
Vancouver
Bao L, Sun H, Zhao Y, Feng L, Wu K, Shang S, et al. Hexadecanamide alleviates Staphylococcus aureus-induced mastitis in mice by inhibiting inflammatory responses and restoring blood-milk barrier integrity. PLOS Pathogens. 2023;19(11):e1011764. doi:10.1371/journal.ppat.1011764
BibTeX
@article{Bao2023,
author = {Bao, Lijuan and Sun, Hao and Zhao, Yihong and Feng, Lianjun and Wu, Keyi and Shang, Shan and Xu, Jiawen and Shan, Ruping and Duan, Shiyu and Qiu, Min and Zhang, Naisheng and Hu, Xiaoyu and Zhao, Caijun and Fu, Yunhe},
title = {Hexadecanamide alleviates Staphylococcus aureus-induced mastitis in mice by inhibiting inflammatory responses and restoring blood-milk barrier integrity},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {11},
pages = {e1011764},
doi = {10.1371/journal.ppat.1011764}
}
EUVIMED